Genetics in Medicine

Papers
(The median citation count of Genetics in Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Table of Contents451
Desperately seeking solutions405
The clinical geneticist workforce: Community forums to address challenges and opportunities367
Where there is no genetic counselor: An online decision-aid supports the majority of parents’ diagnostic genomic testing choices for their children218
Scoping review and classification of deep learning in medical genetics197
Educational considerations based on medical student use of polygenic risk information and apparent race in a simulated consultation187
Cascade testing after exome sequencing: Retrospective analysis of linked family data at 2 US laboratories181
Estimation of carrier frequencies of autosomal and X-linked recessive genetic conditions based on gnomAD v4.0 data in different ancestries129
Expanding the phenotype and genotype spectrum of TAOK1 neurodevelopmental disorder and delineating TAOK2 neurodevelopmental disorder126
Correspondence on “Genomic insights from a deeply phenotyped highly consanguineous neurodevelopmental disorders cohort” by Akter et al124
Editorial Board110
The effect of early hormonal treatment (EHT) on expressive and receptive language capabilities in boys with 47,XXY (Klinefelter syndrome) during infancy and early childhood101
Editorial Board100
Functional genomics for curation of variants in telomere biology disorder associated genes: A systematic review98
Table of Contents95
ClinGen recuration of hearing loss-associated genes demonstrates significant changes in gene-disease validity over time92
Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies92
Biallelic PRMT7 pathogenic variants are associated with a recognizable syndromic neurodevelopmental disorder with short stature, obesity, and craniofacial and digital abnormalities91
Increasing inclusivity in precision medicine research: Views of deaf and hard of hearing individuals76
Editorial Board71
eP169: A case report of Ververi-Brady syndrome: Expanding the genotype and phenotype66
eP234: SERPINA1 sequencing facilitates detection of undiagnosed Alpha-1 antitrypsin deficiency66
eP256: Intrafamilial variability in chromosome 2q13 microdeletion: Case report and review of the literature65
eP162: Mosaic variant in ENG in infant with pulmonary arteriovenous malformations: Case report and review of hereditary hemorrhagic telangiectasia64
Inherited variants in CHD3 show variable expressivity in Snijders Blok-Campeau syndrome64
OP037: Assessing the impact of expanded ACMG secondary findings recommendations on population genomic screening in the Geisinger MyCode Community Health Initiative61
eP498: Detection of congenital cytomegalovirus infection on high-risk newborn population61
eP033: COASY-associated pontocerebellar hypoplasia – A possible additional secondary target detectable by expanded newborn screening?60
eP179: Expanding the phenotype of CLCN6-associated early-onset neurodegeneration60
eP049: Discordant fluorescence in situ hybridization and RNASeq results in the identification of fusion partners in recurring translocations in hematological malignancies60
eP290: A mosaic Angelman syndrome case with language apraxia and symptoms overlapping Prader-Willi syndrome59
Elucidating the clinical spectrum and molecular basis of HYAL2 deficiency58
Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions58
Biallelic DAW1 variants cause a motile ciliopathy characterized by laterality defects and subtle ciliary beating abnormalities58
Paired-like homeobox gene (PHOX2B) nonpolyalanine repeat expansion mutations (NPARMs): genotype–phenotype correlation in congenital central hypoventilation syndrome (CCHS)55
The importance of automation in genetic diagnosis: Lessons from analyzing an inherited retinal degeneration cohort with the Mendelian Analysis Toolkit (MATK)55
OP055: Comparing error rates in disclosure of genome sequencing results between non-genetics providers and genetic counselors55
Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes54
From genes to public health: are we ready for DNA-based population screening?52
eP114: De novo prenatal diagnosis of X-linked Acromegaly Gigantism (X-LAG)50
Improving racial diversity in the genomics workforce: An examination of challenges and opportunities50
eP229: A case report of a complex chromosome 8 rearrangement with partial monosomy of 8p and partial trisomy of 8q49
eP263: A pathogenic deletion at 13q32.1q33.1 presenting with bilateral sensorineural hearing loss and pigmentation anomalies, mimicking Waardenburg syndrome48
eP509: Implementation and impact of dedicated inpatient genetic counselors in a children’s hospital47
eP358: Genetic findings in a cohort of patients with pulmonary arterial hypertension referred for NGS panel testing47
eP512: Identifying clinical and psychological factors associated with genomics-related outcomes in a centralized sequencing protocol46
Challenges for precision public health communication in the era of genomic medicine45
News45
Editorial Board45
Transforming the clinical outcome in CRIM-negative infantile Pompe disease identified via newborn screening: the benefits of early treatment with enzyme replacement therapy and immune tolerance induct44
Universal tumor screening in a population with MSH6- and PMS2-associated Lynch syndrome44
Refining the risk for fragile X–associated primary ovarian insufficiency (FXPOI) by FMR1 CGG repeat size43
Characterization of central manifestations in patients with Niemann-Pick disease type C43
“The truth should not be hidden”: Experiences and recommendations of individuals making NPE discoveries through genetic genealogy databases43
CFTR genotype analysis of Asians in international registries highlights disparities in the diagnosis and treatment of Asian patients with cystic fibrosis42
Genetics providers’ perspectives on the use of digital tools in clinical practice42
Long-term effects of eliglustat on skeletal manifestations in clinical trials of patients with Gaucher disease type 142
eP321: Extending and adapting the functions of genetic laboratories in the continuing COVID pandemic–challenges and successes41
OP048: The impact of route of delivery on surgical morbidity in fetuses affected by achondroplasia: A multicenter retrospective study41
Expanding SPTAN1 monoallelic variant associated disorders: From epileptic encephalopathy to pure spastic paraplegia and ataxia41
eP462: Detection of clinically relevant exonic copy number changes in fetuses by chromosomal microarray analysis40
eP073: Interstitial deletion of 3q21 in a child with multiple congenital anomalies; Expanding the phenotype40
eP018: Late-onset congenital erythropoietic porphyria associated with myeloid malignancy40
eP270: Incorporating genetic services into adult kidney disease care39
eP088: Diagnosing a patient with progressive myoclonic epilepsy-12 with variants of uncertain significance on exome sequencing39
eP244: Rapid exome sequencing influences acute and long-term management of critically unwell children and their families38
eP354: A systematic approach for applying disease-specific phenotype in clinical variant interpretation38
eP005: Complex glycerol kinase deficiency and X-linked intellectual disability38
De novo variants are a common cause of genetic hearing loss37
Calibrating variant curation by clinical context based on factors that influence patients’ tolerance of uncertainty37
The splicing effect of variants at branchpoint elements in cancer genes36
Masthead36
Correspondence on “Genotypic and phenotypic spectrum of infantile liver failure due to pathogenic TRMU variants” by Vogel et al36
Clinical implementation of genetic testing in adults for hereditary hematologic malignancy syndromes35
Exploring Autistic adults’ perspectives on genetic testing for autism34
A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder34
Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections34
Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from Canada34
Updated clinical practice recommendations for managing adults with 22q11.2 deletion syndrome33
Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)33
Reproductive outcomes in individuals with chromosomal reciprocal translocations33
Diagnosing, discarding, or de-VUSsing: A practical guide to (un)targeted metabolomics as variant-transcending functional tests32
The Parent PrU: A measure to assess personal utility of pediatric genomic results32
The opinions and experiences of people with intellectual disability regarding genetic testing and genetic medicine: A systematic review32
Couple-based expanded carrier screening provided by general practitioners to couples in the Dutch general population: psychological outcomes and reproductive intentions32
Documentation of results and medication prescribing after combinatorial psychiatric pharmacogenetic testing: A case for discrete results32
1-13C-propionate breath testing as a surrogate endpoint to assess efficacy of liver-directed therapies in methylmalonic acidemia (MMA)32
Frequency of epistaxis and telangiectasia in patients with hereditary hemorrhagic telangiectasia (HHT) in comparison with the general population: Curaçao diagnostic criteria revisited31
Expanding the genetics and phenotypes of ocular congenital cranial dysinnervation disorders31
Correspondence on “Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: A practice resource of the American College of Medical Genetics and Genomics (ACMG)” by31
Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders31
Awareness and use of genetic testing: An analysis of the Health Information National Trends Survey 202030
Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics29
Clinical spectrum of MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities29
Laboratory business models and practices: implications for availability and access to germline genetic testing29
Evaluating the return of additional findings from the 100,000 Genomes Project: A mixed methods study exploring participant experiences of receiving secondary findings from genomic sequencing28
COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis28
The ACMG SF v3.0 gene list increases returnable variant detection by 22% when compared with v2.0 in the ClinSeq cohort28
Non-adherence to guidelines for genetic testing in families with ovarian cancer shows racial bias28
Risk of cancer in heterozygous relatives of patients with Fanconi anemia28
Response to Shen et al.28
Noncoding variants are a rare cause of recessive developmental disorders in trans with coding variants28
Secondary ACMG and non-ACMG genetic findings in a multiethnic cohort of 16,713 pediatric participants28
Improved detection of mitochondrial DNA instability in mitochondrial genome maintenance disorders28
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire28
Biallelic variation in the choline and ethanolamine transporter FLVCR1 underlies a severe developmental disorder spectrum27
Genome sequencing detects a wide range of clinically relevant copy-number variants and other genomic alterations27
Correspondence on “Comparison of literature mining tools for variant classification: Through the lens of 50 RYR1 variants” by Wermers et al27
Novel insights into the phenotypic spectrum and pathogenesis of Hardikar syndrome27
Masthead27
Response to Stern27
Response to Kiel and Kozaric27
Systematic assessment of outcomes following a genetic diagnosis identified through a large-scale research study into developmental disorders26
Editorial Board26
eP398: Searching beyond the exons in nuclear genes: Diagnostic deep intronic and mitochondrial variants in patients with monogenic diabetes26
eP446: High rates of ‘atypical’ panorama noninvasive prenatal screening results among consanguineous Arab American women26
eP082: Associated recessive retinitis pigmentosa caused by paternal uniparental disomy26
eP342: Clinical testing of SHOX gene for SHOX deficiency disorders26
eP091: Improving cytogenetic testing utilization in a tertiary care NICU through quality improvement26
eP153: WASF2 variants contribute to heart failure phenotypes25
eP364: Lessons from pathogenicity classifications for 251 RYR1 variants associated with malignant hyperthermia susceptibility using variant curation expert panel revised criteria25
eP198: EIF3F compound heterozygous genotype-phenotype association25
Neurofilament light chain in cerebrospinal fluid as a novel biomarker in evaluating both clinical severity and therapeutic response in Niemann-Pick disease type C124
eP249: Practical implementation of inpatient rapid comprehensive sequencing for critically ill pediatric patients24
InpherNet accelerates monogenic disease diagnosis using patients’ candidate genes’ neighbors24
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)24
OP012: Perceptions of breast and ovarian cancer risk and genetic testing among Non-Hispanic Black women24
eP006: Homocystinuria in an adolescent patient with Chr21q22.2q22.3 deletion24
Pregnant Latinas’ views of adopting exome sequencing into newborn screening: A qualitative study24
Pubertal growth in osteogenesis imperfecta caused by pathogenic variants in COL1A1/COL1A224
eP040: Breast cancer patients categorized as high-risk of recurrence and/or basal-type molecular subtype by Agendia should universally undergo germline genetic testing23
eP405: Clinical application of 24-hour ultra-rapid genome sequencing in a critically ill neonate23
eP094: Diagnostic yield of chromosomal microarray in congenital heart disease: A single center retrospective study23
eP128: A novel CSNK1E variant in a patient with autism spectrum disorder23
eP052: Coding defects in chromosomal segregation and protein targeting are central to TGCT predisposition23
eP391: Optical genome mapping for constitutional postnatal SV, CNV, and repeat array sizing: A multi-site clinical study23
eP328: Establishing droplet digital PCR method for assessing mitochondrial DNA content in muscle23
eP164: A case report of neurological manifestations and failure to thrive in neurobehavioural disease caused by a variant in RFX723
eP271: Bi-allelic loss of function variant of the ACTG2 gene that proposes a potential novel mechanism for visceral myopathies23
OP059: Clinical impact of a targeted pharmacogenomic assessment within a cohort of individuals with suspected inborn errors of immunity22
OP046: Stigma manifestations impact patient and clinical outcomes in cardiogenetic care: “Sometimes it’s depressing. Sometimes I feel like giving up.”22
Potential of polygenic risk scores for improving population estimates of women’s breast cancer genetic risks22
Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy22
eP078: Phenotypes and genotypes in a cohort of children with single ventricle congenital heart disease22
eP426: Utilization of the ACMG ACT sheets and algorithms on the ACMG website22
Novel loss-of-function variant in DENND5A impedes melanosomal cargo transport and predisposes to familial cutaneous melanoma22
Mapping the genetic landscape of treatable inherited metabolic disorders in a large Middle Eastern biobank22
OP019: A tertiary care clinical sequencing program for patients with suspected immune defects: Results from the first 1000 families22
Editorial Board22
Masthead22
Automated reanalysis application to assist in detecting novel gene–disease associations after genome sequencing22
The 2019 medical genetics workforce: A focus on laboratory geneticists21
High-affinity FcγRIIIa genetic variants and potent NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) responses contributing to severe COVID-1921
Correspondence on “The evolving role of medical geneticists in the era of gene therapy: An urgency to prepare” by Vockley et al21
Validation of the International Breast Cancer Intervention Study (IBIS) model in the High Risk Ontario Breast Screening Program: A retrospective cohort study21
ORCA, a values-based decision aid for selecting additional findings from genomic sequencing in adults: Efficacy results from a randomized trial21
Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel–Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm study21
Privacy practices using genetic data from cell-free DNA aneuploidy screening21
eP384: Clinical, epidemiological and genetic characteristics of children diagnosed with Multisystem Inflammatory Syndrome (MIS-C) in Kuwait21
Biallelic variants in PCDHGC4 cause a novel neurodevelopmental syndrome with progressive microcephaly, seizures, and joint anomalies21
Focused Revision: Policy statement on folic acid and neural tube defects21
Pancreatic cancer risk to siblings of probands in bilineal cancer settings21
The role of digital tools in the delivery of genomic medicine: enhancing patient-centered care20
Natural history of TANGO2 deficiency disorder: Baseline assessment of 73 patients20
The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant20
High rate of hypomorphic variants as the cause of inherited ataxia and related diseases: study of a cohort of 366 families20
Validation of lung cancer polygenic risk scores in a high-risk case-control cohort20
Meta-analysis of the diagnostic and clinical utility of exome and genome sequencing in pediatric and adult patients with rare diseases across diverse populations20
In This Issue20
Clinical and functional heterogeneity associated with the disruption of retinoic acid receptor beta20
Does the law require reinterpretation and return of revised genomic results?20
Optical genome mapping and revisiting short-read genome sequencing data reveal previously overlooked structural variants disrupting retinal disease−associated genes20
Additional findings from the 100,000 Genomes Project: A qualitative study of recipient perspectives20
SOX11 variants cause a neurodevelopmental disorder with infrequent ocular malformations and hypogonadotropic hypogonadism and with distinct DNA methylation profile19
Table of Contents19
eP383: Mayo Clinic GeneGuide: A population-scale genetic interpretation software for reporting pathogenic and likely pathogenic variants impacting the CDC Tier1 genes19
Standardizing variation: Scaling up clinical genomics in Australia19
eP034: Novel use of global untargeted metabolomics in a patient with glycogen storage disease Ib receiving off label empagliflozin treatment19
Editorial Board19
The impact of genetic counselor involvement in genetic and genomic test order review: A scoping review19
Masthead19
eP248: Impact of DNA methylation signature exploration for variants of uncertain significance within epigenetic syndromes19
eP208: GSD IX natural history and novel liver disease severity score: Multicenter international collaboration uncovers longitudinal trends in liver disease severity19
eP265: Higher rates of non-skeletal complications in achondroplasia compared to the general population: A UK matched cohort study using CPRD-GOLD database19
Editorial Board19
Table of Contents19
eP333: Tracking the emergence of SARS-CoV-2 variants of concern in vaccinated and unvaccinated patients19
eP421: Development of an in-house whole transcriptome test for evaluation of splicing VUS variants: Experience and challenges in variant interpretation19
eP473: Patient attitudes and preferences about expanded noninvasive prenatal screening19
Correction to: The genetic architecture of Plakophilin 2 cardiomyopathy18
The Clinician-reported Genetic Testing Utility Index (C-GUIDE) for Prenatal Care: Initial evidence of content and construct validity18
eP041: How long will they wait? Applying updated NCCN criteria to previously unqualified patients reveals missed opportunities for personalized cancer management18
OP002: Secondary data analysis: Opportunities to advance genetic disease understanding and newborn screening research18
eP429: Factors associated with the time to complete clinical exome sequencing in a pediatric patient population18
Masthead18
De novo PHF5A variants are associated with craniofacial abnormalities, developmental delay, and hypospadias18
eP038: A new biochemical assay to measure plasmalogens with CLIR disease differentiation18
eP154: Predictive genomic medicine for thoracic aortic aneurysm and dissection18
eP272: Familial pathogenic variant causing osteogenesis imperfecta identified in the Puerto Rican population18
Clinical factors associated with genetic diagnosis in suspected neurogenetic disorders in a tertiary care clinic18
Germline variants in HEY2 functional domains lead to congenital heart defects and thoracic aortic aneurysms18
Impact of integrated translational research on clinical exome sequencing18
OP040: Clinical validation of tagmentation-based genome sequencing for germline disorders18
eP376: NGS detection of NUDT15 6-bp insertion and UGT1A1 (TA) repeat polymorphism on a preventative genomics assay18
eP055: The Clinical Genome Resource (ClinGen) Somatic Cancer Clinical Domain Working Group18
Fraud in genetic testing: Swindling the system18
Large scale clinical exome sequencing uncovers the scope and severity of skin disorders associated with MC1R genetic variants17
CIAO1 and MMS19 deficiency: A lethal neurodegenerative phenotype caused by cytosolic Fe-S cluster protein assembly disorders17
Cost-effectiveness of population-wide genomic screening for Lynch Syndrome and polygenic risk scores to inform colorectal cancer screening17
Gene-specific ACMG/AMP classification criteria for germline APC variants: Recommendations from the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel17
Genomic testing for suspected monogenic kidney disease in children and adults: A health economic evaluation17
Improving care for rare genetic neurodevelopmental disorders: A systematic review and critical appraisal of clinical practice guidelines using AGREE II17
Response to Timothé Ménard17
“Doctors shouldn’t have to cheat the system”: Clinicians’ real-world experiences of the utility of genomic sequencing17
Classification of variants of reduced penetrance in high-penetrance cancer susceptibility genes: Framework for genetics clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation G17
The mitochondrial seryl-tRNA synthetase SARS2 modifies onset in spastic paraplegia type 417
Outcomes of prior authorization requests for genetic testing in outpatient pediatric genetics clinics17
PIGG variant pathogenicity assessment reveals characteristic features within 19 families17
The contribution of medical burden to 22q11.2 deletion syndrome quality of life and functioning17
Genetic testing in ambulatory cardiology clinics reveals high rate of findings with clinical management implications17
Biallelic variants in KARS1 are associated with neurodevelopmental disorders and hearing loss recapitulated by the knockout zebrafish17
OP016: Mini-COMET: Safety and efficacy of ≥97 weeks’ avalglucosidase alfa in infantile-onset Pompe disease participants previously treated with alglucosidase alfa17
Genetic Determinants of Sudden Unexpected Death in Pediatrics16
Genome-wide epigenetic signatures facilitated the variant classification of the PURA gene and uncovered the pathomechanism of PURA-related neurodevelopmental disorders16
Functional characteristics of a broad spectrum of TBX6 variants in Mayer-Rokitansky-Küster-Hauser syndrome16
Pathogenic variants in the paired-related homeobox 1 gene (PRRX1) cause craniosynostosis with incomplete penetrance16
Economic evaluation of population-based, expanded reproductive carrier screening for genetic diseases in Australia16
Measurement of lysosomal enzyme activities: A technical standard of the American College of Medical Genetics and Genomics (ACMG)16
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Varia16
Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior16
A systematic review of the methodological quality of economic evaluations in genetic screening and testing for monogenic disorders16
OP011: Physician recommendations after germline sequencing in pediatric cancer patients: Texas KidsCanSeq study15
Table of Contents15
Development and implementation of an electronic medical record module to track genetic testing results15
eP330: Mosaicism for SMARCB1 or LZTR1 variants in patients with schwannomatosis in the UAB cohort15
eP203: Genotype/phenotype correlations in Joubert syndrome15
Diagnosis, treatment and disclosure: A qualitative exploration of participant challenges in a Monogenic Diabetes Registry15
Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study15
Deep phenotyping of 11 individuals with pathogenic variants in RNU4-2 reveals a clinically recognizable syndrome15
Pathogenic variants in CLXN encoding the outer dynein arm docking–associated calcium-binding protein calaxin cause primary ciliary dyskinesia15
eP341: The full (mutation) picture: One-third of patients with Fragile X syndrome present with neurodevelopmental disorders without dysmorphism or family history15
eP418: Enabling reclassification of missense variants in PKD1/2 – the power of a commercial laboratory database15
eP201: A phase 2 clinical trial evaluating the safety and efficacy of delandistrogene moxeparvovec for treating patients with Duchenne muscular dystrophy15
eP108: PPP1CB-related Noonan syndrome with loose anagen hair presenting with focal cortical dysplasia and epilepsy15
OP047: Timely diagnosis of mucopolysaccharidosis: Results from an innovative physician education program with a national outreach15
Editorial Board15
eP125: Variants in obesity-related genes in a population with early-onset obesity15
eP332: The importance of parental sequencing depth in the setting of rapid genome sequencing15
eP520: Screening results in 186 any-health-status adults in primary care clinics receiving clinical NGS for 431 health risk and recessive genes15
eP020: Expanding the clinical spectrum of asparagine synthetase deficiency15
4.6589181423187